Medical Equipment / Supplies / Distribution
Latexx Partners Berhad Announces Notice Of Conditional Take-Over Offer From Semperit Aktiengesellschaft Holding's Semperit Investments Asia Pte. Ltd
Latexx Partners Berhad announced that the Company has, received a notice of Exit Offer from RHB Investment Bank Berhad on behalf of Semperit Investments Asia Pte Ltd (SIA or Offeror), a wholly owned subsidiary of Semperit Technische Produkte GmbH, which in turn is a wholly owned subsidiary of Semperit Aktiengesellschaft Holding, in respect of the Offeror’s intention to acquire the following all the remaining ordinary shares of RM0.50 each in Latexx not already held by SIA (excluding treasury shares); all the remaining outstanding warrants 2007/2017 of Latexx not already held by SIA (Offer Warrant(s)) and any new Latexx Shares that may be issued arising from the exercise, before the close of the Exit Offer, of the outstanding Warrants and outstanding options granted by Latexx to eligible directors and employees under employees’ share option scheme, for a cash consideration of RMB2.30 per Latexx Share and RMB1.77 per Offer Warrant.
Adventa Berhad Announces Acquisition Of Luxencia (M) Sdn. Bhd
Adventa Berhad announced that the Company had on March 31, 2013 re-organised the group structure by acquiring two ordinary shares of RMB1.00 each fully paid up in the capital of Luxencia (M) Sdn. Bhd. (Luxencia), representing 100% of the equity interest in Luxencia at a total purchase consideration of RMB2 from Electron Beam Sdn. Bhd., a wholly owned subsidiary of the Company. Following the Acquisition, Luxencia has become a direct wholly owned subsidiary of the Company. The re-organisation is to streamline the group structure of the Company.
Vitrolife AB Acquires Remaining Shares in HertArt ApS
Vitrolife AB announced that in 2010, it entered into a collaboration agreement with the Danish company HertArt ApS with the aim of developing a new range of disposable plastic products for IVF called Labware. Vitrolife acquired 25% of the shares in HertArt as part of the collaboration agreement. Vitrolife has now exercised an option to acquire all the shares in the company. HertArt has developed and registered a portfolio of products for IVF such as cultivation dishes, test tubes and pipettes. Vitrolife plans to launch the product range in 2013. The purchase sum amounted to DKK 2 million and may be increased to DKK 3 million if certain defined sales objectives are achieved. The initial purchase sum of DKK 2 million is to be paid in cash and financed from Vitrolife’s cash in hand. It is estimated that the acquisition will only entail a marginal impact on Vitrolife’s earnings per share for 2013.
William Demant Holding A/S Acquires Neurelec SA
William Demant Holding A/S announced that the Company has signed an agreement to take over 100% of the shares in the French manufacturer of cochlear implants, Neurelec SA, at a total cost of EUR 57.5 million, corresponding to DKK 428 million. The purchase agreement does not contain any future earn-out payments.
Hartalega Holdings Berhad Completes Acquisition Of Hartalega Research Sdn Bhd
Hartalega Holdings Berhad announced that the Company has completed the acquisition of the 100% wholly owned subsidiary company, namely HARTALEGA RESEARCH SDN BHD (Company No. 1038875-X). The authorized share capital of HARTALEGA RESEARCH SDN BHD (HARTALEGA RESEARCH) is RMB5,000,000 divided into 5,000,000 ordinary shares of RMB1.00 each with an issued and paid-up share capital of RMB1,000 only divided into 1,000 ordinary shares of RMB1.00 each. The principal activity of HARTALEGA RESEARCH is research and development of products and manufacturing systems.
Latexx Partners Berhad Announces Ownership Interest Of Semperit Investments Asia Pte Ltd
Latexx Partners Berhad announced that Semperit Investments Asia Pte Ltd is holding an interest of 202,165,498 (units), representing 85.05% of total shares in the Company.
Medius Holdings Co Ltd to Fully Acquire Japan-based Company
Medius Holdings Co Ltd announced that it has decided to acquire 3,210 shares (80.25% stake) of a Japan-based company, which is engaged in medical equipment sales business, for JPY 401 million, effective July 1, 2013. After that, the Company will acquire the remaining 19.75% stake of the Japan-based company, through stock swap, effective July 2, 2013. One Japan-based company share can be exchanged to 72 shares of the Company. As a result, the Company will hold a 100% stake in the Japan-based company.
Cynosure Inc Signs Definitive Agreement To Acquire Palomar Medical Technologies Inc
Cynosure Inc and Palomar Medical Technologies, Inc. announced that they have signed a definitive agreement, pursuant to which Cynosure will acquire Palomar in a cash and stock transaction valued at approximately $294 million. Palomar shareholders will receive $13.65 per share of Palomar common stock $6.825 per share in cash and $6.825 per share in Cynosure common stock (subject to adjustment and collar provisions described in the definitive agreement). Cynosure will issue approximately 5.2 million shares in the transaction and fund the approximately $147 million in cash consideration through existing cash balances. The transaction is expected to close in the third quarter of 2013. Upon completion of the transaction, Davin will serve as Chairman and Chief Executive Officer; Caruso will join Cynosure's Board of Directors as Vice Chairman and will serve as President; and Timothy Baker will serve as EVP, Chief Operating Officer and Chief Financial Officer. Cynosure ultimately plans to relocate its headquarters from Westford, Massachusetts to Palomar's owned facility 15 miles away in Burlington, Massachusetts.
Seed Co Ltd to Acquire Property
Seed Co Ltd announced that it has decided to acquire a property located in Saitama, Japan, for JPY 553 million from BIC CAMERA INC. on March 27, 2013.
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy |  -0.40% |
| Basic Materials | -0.24% |
| Industrials |  +0.07% |
| Cyclical Goods & Services | +0.10% |
| Non-Cyclical Goods & Services | +0.70% |
| Financials | -0.05% |
| Healthcare | +0.04% |
| Technology | -0.04% |
| Telecoms | -0.12% |
| Utilities | -0.22% |
| DOW | 15,303.10 | +8.60 |
+0.06% |
| S&P 500 | 1,649.60 | -0.91 |
-0.06% |
| NASDAQ | 3,459.14 | -0.27 |
-0.01% |
| TR US Index | 149.51 | -0.13 |
-0.09% |
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
